IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-38435-3.html
   My bibliography  Save this article

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

Author

Listed:
  • Tomokazu Tamura

    (Hokkaido University
    Hokkaido University)

  • Jumpei Ito

    (The University of Tokyo)

  • Keiya Uriu

    (The University of Tokyo
    The University of Tokyo)

  • Jiri Zahradnik

    (Weizmann Institute of Science
    Charles University)

  • Izumi Kida

    (Hokkaido University)

  • Yuki Anraku

    (Hokkaido University)

  • Hesham Nasser

    (Kumamoto University
    Suez Canal University)

  • Maya Shofa

    (University of Miyazaki
    University of Miyazaki)

  • Yoshitaka Oda

    (Hokkaido University)

  • Spyros Lytras

    (Medical Research Council-University of Glasgow Centre for Virus Research)

  • Naganori Nao

    (Hokkaido University
    Hokkaido University)

  • Yukari Itakura

    (Hokkaido University
    Hokkaido University)

  • Sayaka Deguchi

    (Kyoto University)

  • Rigel Suzuki

    (Hokkaido University
    Hokkaido University)

  • Lei Wang

    (Hokkaido University
    Hokkaido University)

  • MST Monira Begum

    (Kumamoto University)

  • Shunsuke Kita

    (Hokkaido University)

  • Hisano Yajima

    (Kyoto University)

  • Jiei Sasaki

    (Kyoto University)

  • Kaori Sasaki-Tabata

    (Kyushu University)

  • Ryo Shimizu

    (Kumamoto University)

  • Masumi Tsuda

    (Hokkaido University
    Hokkaido University)

  • Yusuke Kosugi

    (The University of Tokyo
    The University of Tokyo)

  • Shigeru Fujita

    (The University of Tokyo
    The University of Tokyo)

  • Lin Pan

    (The University of Tokyo
    The University of Tokyo)

  • Daniel Sauter

    (The University of Tokyo
    University Hospital Tübingen)

  • Kumiko Yoshimatsu

    (Hokkaido University)

  • Saori Suzuki

    (Hokkaido University
    Hokkaido University)

  • Hiroyuki Asakura

    (Tokyo Metropolitan Institute of Public Health)

  • Mami Nagashima

    (Tokyo Metropolitan Institute of Public Health)

  • Kenji Sadamasu

    (Tokyo Metropolitan Institute of Public Health)

  • Kazuhisa Yoshimura

    (Tokyo Metropolitan Institute of Public Health)

  • Yuki Yamamoto

    (HiLung, Inc.)

  • Tetsuharu Nagamoto

    (HiLung, Inc.)

  • Gideon Schreiber

    (Weizmann Institute of Science)

  • Katsumi Maenaka

    (Hokkaido University
    Hokkaido University
    Hokkaido University
    Hokkaido University)

  • Takao Hashiguchi

    (Kyoto University
    CREST, Japan Science and Technology Agency)

  • Terumasa Ikeda

    (Kumamoto University)

  • Takasuke Fukuhara

    (Hokkaido University
    Hokkaido University
    AMED-CREST, Japan Agency for Medical Research and Development (AMED)
    Osaka University)

  • Akatsuki Saito

    (University of Miyazaki
    University of Miyazaki
    University of Miyazaki)

  • Shinya Tanaka

    (Hokkaido University
    Hokkaido University)

  • Keita Matsuno

    (Hokkaido University
    Hokkaido University
    Hokkaido University
    Hokkaido University)

  • Kazuo Takayama

    (Kyoto University
    CREST, Japan Science and Technology Agency)

  • Kei Sato

    (The University of Tokyo
    The University of Tokyo
    The University of Tokyo
    CREST, Japan Science and Technology Agency)

Abstract

In late 2022, SARS-CoV-2 Omicron subvariants have become highly diversified, and XBB is spreading rapidly around the world. Our phylogenetic analyses suggested that XBB emerged through the recombination of two cocirculating BA.2 lineages, BJ.1 and BM.1.1.1 (a progeny of BA.2.75), during the summer of 2022. XBB.1 is the variant most profoundly resistant to BA.2/5 breakthrough infection sera to date and is more fusogenic than BA.2.75. The recombination breakpoint is located in the receptor-binding domain of spike, and each region of the recombinant spike confers immune evasion and increases fusogenicity. We further provide the structural basis for the interaction between XBB.1 spike and human ACE2. Finally, the intrinsic pathogenicity of XBB.1 in male hamsters is comparable to or even lower than that of BA.2.75. Our multiscale investigation provides evidence suggesting that XBB is the first observed SARS-CoV-2 variant to increase its fitness through recombination rather than substitutions.

Suggested Citation

  • Tomokazu Tamura & Jumpei Ito & Keiya Uriu & Jiri Zahradnik & Izumi Kida & Yuki Anraku & Hesham Nasser & Maya Shofa & Yoshitaka Oda & Spyros Lytras & Naganori Nao & Yukari Itakura & Sayaka Deguchi & Ri, 2023. "Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
  • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-38435-3
    DOI: 10.1038/s41467-023-38435-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-38435-3
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-023-38435-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Jun Lan & Jiwan Ge & Jinfang Yu & Sisi Shan & Huan Zhou & Shilong Fan & Qi Zhang & Xuanling Shi & Qisheng Wang & Linqi Zhang & Xinquan Wang, 2020. "Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor," Nature, Nature, vol. 581(7807), pages 215-220, May.
    2. Yunlong Cao & Fanchong Jian & Jing Wang & Yuanling Yu & Weiliang Song & Ayijiang Yisimayi & Jing Wang & Ran An & Xiaosu Chen & Na Zhang & Yao Wang & Peng Wang & Lijuan Zhao & Haiyan Sun & Lingling Yu , 2023. "Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution," Nature, Nature, vol. 614(7948), pages 521-529, February.
    3. Akatsuki Saito & Takashi Irie & Rigel Suzuki & Tadashi Maemura & Hesham Nasser & Keiya Uriu & Yusuke Kosugi & Kotaro Shirakawa & Kenji Sadamasu & Izumi Kimura & Jumpei Ito & Jiaqi Wu & Kiyoko Iwatsuki, 2022. "Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation," Nature, Nature, vol. 602(7896), pages 300-306, February.
    4. Seiya Ozono & Yanzhao Zhang & Hirotaka Ode & Kaori Sano & Toong Seng Tan & Kazuo Imai & Kazuyasu Miyoshi & Satoshi Kishigami & Takamasa Ueno & Yasumasa Iwatani & Tadaki Suzuki & Kenzo Tokunaga, 2021. "SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity," Nature Communications, Nature, vol. 12(1), pages 1-9, December.
    5. Peter J. Halfmann & Shun Iida & Kiyoko Iwatsuki-Horimoto & Tadashi Maemura & Maki Kiso & Suzanne M. Scheaffer & Tamarand L. Darling & Astha Joshi & Samantha Loeber & Gagandeep Singh & Stephanie L. Fos, 2022. "SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters," Nature, Nature, vol. 603(7902), pages 687-692, March.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Tomokazu Tamura & Takashi Irie & Sayaka Deguchi & Hisano Yajima & Masumi Tsuda & Hesham Nasser & Keita Mizuma & Arnon Plianchaisuk & Saori Suzuki & Keiya Uriu & Mst Monira Begum & Ryo Shimizu & Michae, 2024. "Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    2. Orsolya Anna Pipek & Anna Medgyes-Horváth & József Stéger & Krisztián Papp & Dávid Visontai & Marion Koopmans & David Nieuwenhuijse & Bas B. Oude Munnink & István Csabai, 2024. "Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
    3. Dhiraj Mannar & James W. Saville & Chad Poloni & Xing Zhu & Alison Bezeruk & Keith Tidey & Sana Ahmed & Katharine S. Tuttle & Faezeh Vahdatihassani & Spencer Cholak & Laura Cook & Theodore S. Steiner , 2024. "Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 XBB.1.5 spike protein," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
    4. Cassia Wagner & Kathryn E. Kistler & Garrett A. Perchetti & Noah Baker & Lauren A. Frisbie & Laura Marcela Torres & Frank Aragona & Cory Yun & Marlin Figgins & Alexander L. Greninger & Alex Cox & Hann, 2024. "Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution," Nature Communications, Nature, vol. 15(1), pages 1-12, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jumpei Ito & Rigel Suzuki & Keiya Uriu & Yukari Itakura & Jiri Zahradnik & Kanako Terakado Kimura & Sayaka Deguchi & Lei Wang & Spyros Lytras & Tomokazu Tamura & Izumi Kida & Hesham Nasser & Maya Shof, 2023. "Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    2. Zhennan Zhao & Yufeng Xie & Bin Bai & Chunliang Luo & Jingya Zhou & Weiwei Li & Yumin Meng & Linjie Li & Dedong Li & Xiaomei Li & Xiaoxiong Li & Xiaoyun Wang & Junqing Sun & Zepeng Xu & Yeping Sun & W, 2023. "Structural basis for receptor binding and broader interspecies receptor recognition of currently circulating Omicron sub-variants," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    3. James Brett Case & Samantha Mackin & John M. Errico & Zhenlu Chong & Emily A. Madden & Bradley Whitener & Barbara Guarino & Michael A. Schmid & Kim Rosenthal & Kuishu Ren & Ha V. Dang & Gyorgy Snell &, 2022. "Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    4. Mingxi Li & Yifei Ren & Zhen Qin Aw & Bo Chen & Ziqing Yang & Yuqing Lei & Lin Cheng & Qingtai Liang & Junxian Hong & Yiling Yang & Jing Chen & Yi Hao Wong & Jing Wei & Sisi Shan & Senyan Zhang & Jiwa, 2022. "Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    5. Srikanth Sadhu & Rajdeep Dalal & Jyotsna Dandotiya & Akshay Binayke & Virendra Singh & Manas Ranjan Tripathy & Vinayaka Das & Sandeep Goswami & Shakti Kumar & Zaigham Abbas Rizvi & Amit Awasthi, 2023. "IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    6. Naoko Iwata-Yoshikawa & Masatoshi Kakizaki & Nozomi Shiwa-Sudo & Takashi Okura & Maino Tahara & Shuetsu Fukushi & Ken Maeda & Miyuki Kawase & Hideki Asanuma & Yuriko Tomita & Ikuyo Takayama & Shutoku , 2022. "Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    7. Ryuta Uraki & Shun Iida & Peter J. Halfmann & Seiya Yamayoshi & Yuichiro Hirata & Kiyoko Iwatsuki-Horimoto & Maki Kiso & Mutsumi Ito & Yuri Furusawa & Hiroshi Ueki & Yuko Sakai-Tagawa & Makoto Kuroda , 2023. "Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    8. Mai Komori & Takuto Nogimori & Amber L. Morey & Takashi Sekida & Keiko Ishimoto & Matthew R. Hassett & Yuji Masuta & Hirotaka Ode & Tomokazu Tamura & Rigel Suzuki & Jeff Alexander & Yasutoshi Kido & K, 2023. "saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    9. Tomokazu Tamura & Takashi Irie & Sayaka Deguchi & Hisano Yajima & Masumi Tsuda & Hesham Nasser & Keita Mizuma & Arnon Plianchaisuk & Saori Suzuki & Keiya Uriu & Mst Monira Begum & Ryo Shimizu & Michae, 2024. "Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    10. Pengcheng Han & Chao Su & Yanfang Zhang & Chongzhi Bai & Anqi Zheng & Chengpeng Qiao & Qing Wang & Sheng Niu & Qian Chen & Yuqin Zhang & Weiwei Li & Hanyi Liao & Jing Li & Zengyuan Zhang & Heecheol Ch, 2021. "Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants," Nature Communications, Nature, vol. 12(1), pages 1-9, December.
    11. Zhenzhen Wang & Shiqi Hu & Kristen D. Popowski & Shuo Liu & Dashuai Zhu & Xuan Mei & Junlang Li & Yilan Hu & Phuong-Uyen C. Dinh & Xiaojie Wang & Ke Cheng, 2024. "Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    12. Tamara Kaleta & Lisa Kern & Samuel Leandro Hong & Martin Hölzer & Georg Kochs & Julius Beer & Daniel Schnepf & Martin Schwemmle & Nena Bollen & Philipp Kolb & Magdalena Huber & Svenja Ulferts & Sebast, 2022. "Antibody escape and global spread of SARS-CoV-2 lineage A.27," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    13. Taha Y. Taha & Irene P. Chen & Jennifer M. Hayashi & Takako Tabata & Keith Walcott & Gabriella R. Kimmerly & Abdullah M. Syed & Alison Ciling & Rahul K. Suryawanshi & Hannah S. Martin & Bryan H. Bach , 2023. "Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    14. Guoli Shi & Tiansheng Li & Kin Kui Lai & Reed F. Johnson & Jonathan W. Yewdell & Alex A. Compton, 2024. "Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    15. Hannah McClymont & Wenbiao Hu, 2021. "Weather Variability and COVID-19 Transmission: A Review of Recent Research," IJERPH, MDPI, vol. 18(2), pages 1-19, January.
    16. Ankita Leekha & Arash Saeedi & Monish Kumar & K. M. Samiur Rahman Sefat & Melisa Martinez-Paniagua & Hui Meng & Mohsen Fathi & Rohan Kulkarni & Kate Reichel & Sujit Biswas & Daphne Tsitoura & Xinli Li, 2024. "An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
    17. Felix Dewald & Martin Pirkl & Martha Paluschinski & Joachim Kühn & Carina Elsner & Bianca Schulte & Jacqueline Knüfer & Elvin Ahmadov & Maike Schlotz & Göksu Oral & Michael Bernhard & Mark Michael & M, 2023. "Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    18. Nikhil Kumar Tulsian & Raghuvamsi Venkata Palur & Xinlei Qian & Yue Gu & Bhuvaneshwari D/O Shunmuganathan & Firdaus Samsudin & Yee Hwa Wong & Jianqing Lin & Kiren Purushotorman & Mary McQueen Kozma & , 2023. "Defining neutralization and allostery by antibodies against COVID-19 variants," Nature Communications, Nature, vol. 14(1), pages 1-23, December.
    19. Neeltje van Doremalen & Jonathan E. Schulz & Danielle R. Adney & Taylor A. Saturday & Robert J. Fischer & Claude Kwe Yinda & Nazia Thakur & Joseph Newman & Marta Ulaszewska & Sandra Belij-Rammerstorfe, 2022. "ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    20. Leire Campos-Mata & Benjamin Trinité & Andrea Modrego & Sonia Tejedor Vaquero & Edwards Pradenas & Anna Pons-Grífols & Natalia Rodrigo Melero & Diego Carlero & Silvia Marfil & César Santiago & Dàlia R, 2024. "A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity," Nature Communications, Nature, vol. 15(1), pages 1-13, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-38435-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.